Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Pega Unlocks AI Potential in Q3 2025
-
Solo Brands, Inc. Fiscal 2025 Third Quarter Financial Results To Be Released Thursday, November 6, 2025
-
Manhattan Associates Reports Third Quarter Results
-
Exelixis to Release Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
-
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
-
Jamieson Wellness Inc. Announces Appointment of New Board Director
-
LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025
-
East West Bancorp Reports Record Quarterly Net Income of $368 Million and Diluted Earnings Per Share of $2.65; Record Fees, Loans, and Deposits
-
Meta Announces Joint Venture with Funds Managed by Blue Owl Capital to Develop Hyperion Data Center
-
NOG Provides Third Quarter Update
-
Manhattan Associates Announces Appointment of Greg Betz as Chief Operating Officer
-
AST SpaceMobile Announces Proposed Repurchase of up to $50.0 Million Convertible Senior Notes to be Funded By Concurrent Registered Direct Offering of Class A Common Stock
-
Ramaco Resources, Inc. to Release Third Quarter 2025 Financial Results on Monday, October 27, 2025 and Host Conference Call and Webcast on Tuesday, October 28, 2025
-
P3 Health Partners Schedules Third Quarter 2025 Earnings Release and Conference Call
-
New Jersey American Water and Gordon’s Corner Water Company Reach Acquisition Agreement
-
Sherwin-Williams Declares Dividend of $0.79 per Common Share
-
Onto Innovation to Report Third Quarter 2025 Financial Results on November 6, 2025
-
Finance of America Announces Third Quarter Earnings Release and Conference Call on November 4, 2025
-
Rocky Brands, Inc. to Report Third Quarter 2025 Results on October 28, 2025
-
Magnachip to Announce Third Quarter 2025 Financial Results on November 3, 2025
-
Toast Announces Release Date of Third Quarter 2025 Financial Results
-
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
-
Coupang to Announce Third Quarter 2025 Results on November 4, 2025
-
Getty Realty Corp. Announces Increased Quarterly Cash Dividend
-
Inspired to Report Third Quarter 2025 Results and Hold Conference Call on November 5
-
Bitfarms Announces Closing of US$500 Million of Convertible Senior Notes
-
MARA Schedules Conference Call for Third Quarter 2025 Financial Results
-
Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity
-
Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025
-
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update
-
The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital Transformation Officer
-
Intuitive Announces Third Quarter Earnings
-
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025
-
Xometry to Announce Third Quarter 2025 Financial Results on November 4, 2025
-
Beyond Meat® to Report Third Quarter 2025 Financial Results on November 4, 2025
-
AvePoint to Announce Third Quarter 2025 Financial Results on November 6
-
Synchronoss Technologies Announces Third Quarter 2025 Earnings Call Date
-
Matrix Service Company Sets Date for Release of Fiscal Year 2026 First Quarter Results and Conference Call
-
Remitly to Report Third Quarter Financial Results on November 5, 2025
-
InspireMD to Announce Third Quarter 2025 Financial Results
-
Children’s Hospital Los Angeles Bariatric Surgery Program Earns National Accreditation from the American College of Surgeons
-
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
-
Monarch Casino & Resort Reports All-Time Record Quarterly Financial Results
-
Omnicom Reports Third Quarter 2025 Results
-
Ibotta To Announce Third Quarter 2025 Financial Results on November 12, 2025
-
Can Ozempic Slow Aging? New Study Raises Hope
-
KBRA Assigns Preliminary Ratings to MSBAM 2025-5C2
-
XXIX's Opemiska PEA Confirms Positive Development Potential
-
Odyssey Resources Grants Incentive Stock Options
-
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
